glp-1 employer coverage news october 2025 Debate Comes Down to a 'Prisoner's Dilemma,' Lilly SVP Says The GLP-1 Access Gap: Mapping
Description
A consensus report by the american diabetes association (ADA) and the european association for the study of diabetes (EASD)
The ongoing multidistrict litigation (MDL) against pharmaceutical giants Novo Nordisk and Eli Lilly concerning GLP-1 drugs, including Ozempic, Wegovy, Trulicity, and Mounjaro, continues to develop as plaintiffs claim these medications have caused serious gastrointestinal injuries
Semaglutide with glycine and tirzepatide with glycine are increasingly popular combination protocols
In fact, clinical trials show that these medications work best in conjunction with education on eating and exercise
We also expand on these findings by showing that KO of CNS GIPR can sensitize the response to GLP-1R agonism and that CNS GIPR is necessary for the maximal weight loss response to mGIPR-Ab/GLP-1
The Proglucagon to GLP-1 Conversion L-cells contain the gene GCG, which encodes proglucagonthe precursor molecule for GLP-1
